Polymer nanocarriers for the delivery of small fragments of nucleic acids: Oligonucleotides and siRNA

被引:87
作者
de Martimprey, H. [2 ]
Vauthier, C.
Malvy, C. [2 ]
Couvreur, P. [1 ]
机构
[1] Univ Paris Sud, CNRS, UMR 8612, F-92296 Chatenay Malabry, France
[2] Inst Gustave Roussy, Villejuif, France
关键词
Nanocarriers; Nanoparticles; Polymer micelles; Nanocapsules; RNA interference; RNAi; siRNA; Oligonucleotides; ODN; DOUBLE-STRANDED-RNA; CATIONIC FUSOGENIC PEPTIDE; IN-VIVO; ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA; GENE DELIVERY; NONVIRAL DELIVERY; INTERFERING RNA; PLASMID DNA; POLYALKYLCYANOACRYLATE NANOPARTICLES;
D O I
10.1016/j.ejpb.2008.09.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The success of the application of new therapeutic methods based on RNA interfering strategies requires the in vivo delivery of active ODN or siRNA down to the intracellular compartment of the target cells. This article aims to review the studies related to the formulation of RNA interfering agents in polymer nanocarriers. It will present the different types of polymer nanocarriers used as well as the biological activity of the resulting ODN and siRNA loaded nanocarriers. As will be explained, the part of the in vitro studies provided useful data about the intracellular delivery of the formulated RNA interfering agents. Investigations performed in vivo have considered animal models of different relevant diseases. Results from these investigations have clearly demonstrated the interest of several polymer nanocarriers tested so far to deliver active RNA interfering effectors in vivo making possible their administration by the intravenous route. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:490 / 504
页数:15
相关论文
共 119 条
[1]   PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES [J].
AGRAWAL, S ;
TEMSAMANI, J ;
GALBRAITH, W ;
TANG, JY .
CLINICAL PHARMACOKINETICS, 1995, 28 (01) :7-16
[2]   Nonviral delivery of synthetic siRNAs in vivo [J].
Akhtar, Saghir ;
Benter, Ibrahim F. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3623-3632
[3]   Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis [J].
Akinc, A ;
Thomas, M ;
Klibanov, AM ;
Langer, R .
JOURNAL OF GENE MEDICINE, 2005, 7 (05) :657-663
[4]   Antisense approaches for investigating mechanisms of abnormal development [J].
Augustine, K .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 396 (1-2) :175-193
[5]   Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides [J].
Aynié, I ;
Vauthier, C ;
Chacun, H ;
Fattal, E ;
Couvreur, P .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (03) :301-312
[6]   Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles [J].
Bartlett, Derek W. ;
Davis, Mark E. .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 99 (04) :975-985
[7]   Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles [J].
Bartlett, Derek W. ;
Davis, Mark E. .
BIOCONJUGATE CHEMISTRY, 2007, 18 (02) :456-468
[8]   Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging [J].
Bartlett, Derek W. ;
Su, Helen ;
Hildebrandt, Isabel J. ;
Weber, Wolfgang A. ;
Davis, Mark E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) :15549-15554
[9]   Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: Influences of surface morphology, length, and type of polysaccharide [J].
Bertholon, Isabelle ;
Vauthier, Christine ;
Labarre, Denis .
PHARMACEUTICAL RESEARCH, 2006, 23 (06) :1313-1323
[10]   Characterization of dextran-poly(isobutylcyanoacrylate) copolymers obtained by redox radical and anionic emulsion polymerization [J].
Bertholon, Isabelle ;
Lesieur, Sylviane ;
Labarre, Denis ;
Besnard, Madeleine ;
Vauthier, Christine .
MACROMOLECULES, 2006, 39 (10) :3559-3567